Panagiotis Ferentinos Selected Research

Catatonia

1/2009

Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Panagiotis Ferentinos Research Topics

Disease

6	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 02/2014
5	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2018
3	Schizophrenia (Dementia Praecox) 01/2022 - 09/2012
2	Drug-Related Side Effects and Adverse Reactions 02/2024 - 09/2012
2	Heart Failure 11/2023 - 04/2022
2	Inflammation (Inflammations) 11/2023 - 10/2021
2	Multiple Sclerosis 06/2023 - 02/2022
2	Mood Disorders (Mood Disorder) 01/2022 - 01/2016
2	Genetic Risk Score 01/2022 - 01/2021
2	Neuroleptic Malignant Syndrome 09/2012 - 01/2009
1	Necrosis 11/2023
1	Sarcopenia 06/2023
1	Treatment-Resistant Depressive Disorder 01/2023
1	Hypertension (High Blood Pressure) 11/2022
1	Dyslipidemias (Dyslipidemia) 11/2022
1	Peripheral Arterial Disease 04/2022
1	Acute Coronary Syndrome 04/2022
1	Hemorrhage 01/2022
1	COVID-19 01/2022
1	Cognitive Dysfunction 01/2022
1	Mental Disorders (Mental Disorder) 01/2021
1	Mania (Manias) 10/2017
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2016
1	Urinary Retention 11/2016
1	Alcohol-Related Disorders 01/2016
1	Restless Legs Syndrome (Restless Legs) 02/2014
1	Tardive Dyskinesia 09/2012
1	Hyperprolactinemia 09/2012
1	Agranulocytosis (Granulocytopenia) 09/2012
1	Weight Gain 09/2012
1	Psychotic Disorders (Schizoaffective Disorder) 04/2011
1	Dyskinesias (Dyskinesia) 10/2010
1	Hypothyroidism 09/2009
1	Somnambulism (Sleepwalking) 02/2009
1	Catatonia 01/2009

Drug/Important Bio-Agent (IBA)

4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2021
3	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 04/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2023 - 06/2023
2	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2021
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2021
2	Quetiapine Fumarate (Seroquel)FDA Link 02/2014 - 09/2009
2	Clozapine (Clozaril)FDA LinkGeneric 09/2012 - 01/2009
1	Interleukin-6 (Interleukin 6)IBA 11/2023
1	C-Reactive ProteinIBA 11/2023
1	CytokinesIBA 11/2023
1	AntioxidantsIBA 06/2023
1	Vitamin D FDA LinkGeneric 06/2023
1	Cholecalciferol (Vitamin D3)FDA Link 06/2023
1	Essential Amino AcidsIBA 06/2023
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2022
1	erucylphosphocholineIBA 04/2022
1	Coenzyme A (CoA)IBA 02/2022
1	Oxidoreductases (Dehydrogenase)IBA 02/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022
1	Fondaparinux (Arixtra)FDA Link 01/2022
1	LithiumIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	fasudil (AT 877)IBA 10/2021
1	rho-Associated KinasesIBA 10/2021
1	Glycogen Synthase Kinase 3 betaIBA 10/2021
1	Dehydroepiandrosterone (DHEA)IBA 01/2021
1	FurinIBA 01/2021
1	SolutionsIBA 11/2019
1	BenzodiazepinesIBA 01/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2017
1	Escitalopram FDA Link 11/2016
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2016
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 02/2014
1	Calcium Channels (Calcium Channel)IBA 02/2014
1	Bupropion (Wellbutrin)FDA LinkGeneric 10/2010
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2009
1	zopiclone (Zop)IBA 02/2009

Therapy/Procedure

1	Polypharmacy 02/2024
1	Glycemic Control 11/2022
1	Prostatectomy (Retropubic Prostatectomy) 11/2016